Weekly Market Roundup
Creative Medical Technology Surges 100% on Patent News, Plus a Reverse Merger and a Record Week for Gold Stocks
A patent that hasn’t even issued yet sent a thinly traded diabetes stock up 100% in a single session on 25 times its normal volume. A Utah AV equipment maker filed routine merger paperwork and jumped 98% after hours, even though the deal leaves its own shareholders with barely a tenth of the combined company.…
Neptune Digital Assets Sells Free Ionic Digital Shares for $234,000
A Vancouver crypto holding company just turned a free stock windfall into over two hundred thousand dollars without spending a cent to acquire it. In Toronto, a fintech company that posted its first-ever profitable quarter this spring just raised its own revenue forecast by up to $30 million, based on a single month of sales.…
IsoEnergy Forms $105M-Backed DISA Uranium Venture as Two Clean Energy Stocks Slide on Fresh Disclosures
A Toronto uranium miner just handed off a chunk of its Utah portfolio to a brand-new company backed by $105 million from strategic investors including a mining major and an oilfield services giant. A battery materials company’s own financing announcement knocked more than 20% off its stock the next day. And a solar technology company…
Alchemy Labs Expands ExoShield to the Ford F-Series, Plus Two Other Small-Cap Tech Moves
Alchemy Labs went public less than a month ago selling windshield film and defense coatings out of the same balance sheet, and it just added one of the best-selling trucks in North America to its customer list. A post-quantum cybersecurity company that still books well under $50,000 a year in revenue just pulled in $5.3…
Capricor’s Deramiocel Voted Down 9-3 by FDA Advisory Panel
Nine advisory committee members looked at the same trial data Capricor called a win and voted against it. The 9-3 result on July 29 didn’t kill Capricor’s Duchenne muscular dystrophy program, but it added a real question mark to a therapy the company insists already cleared its bar. INmune Bio spent the same stretch doing…
America’s Antimony Push Gets a Pilot Plant. One Junior Is Already Finding More
The U.S. Army and Idaho National Laboratory opened a modular pilot plant in Idaho Falls built to process antimony, a mineral used in ammunition, batteries, and flame retardants that the United States currently gets almost entirely from China and Russia. A day earlier, a small New Brunswick company reported another round of high-grade antimony assays…
FinWise Bancorp Q2 Profit Falls 22% After Tallied Technologies Buy
A bitcoin miner born out of one of crypto’s ugliest bankruptcies just staged the biggest direct listing Nasdaq has seen in five years. Two days later, a small Utah bank holding company reported its profit fell by more than a fifth, undercut in part by the very acquisition it made ten days earlier to bring…
Graphene Manufacturing Group Lands Blackwoods Distribution Deal as Two Nasdaq Financings Send Stocks in Opposite Directions
Blackwoods has stocked industrial supplies for Australian mines and factories since 1878. This month it added a liquid graphene lubricant to that catalog. Elsewhere, a $50 million financing priced above a stock’s own market value sent one Nasdaq micro-cap tumbling, while a much smaller facility sent another soaring in the same week. GMG Lands Blackwoods…
QumulusAI Signs $71.9 Million AI Deal as Argo Corporation Closes $10 Million Raise and Nextech3D.ai Moves to Reacquire ARway
QumulusAI went public two weeks ago. It has already signed four separate GPU supply agreements worth more than $140 million combined, the latest landing Tuesday at $71.9 million on its own. A transit-tech company priced its newest institutional raise below where it priced its last two, and called it a strategic investment anyway. Nextech3D.ai, a…










